Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in VYGR — Voyager Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$544,341
+$92,420 QoQ
Shares Held
155,526
+32.8% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 135 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. VYGR ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in VYGR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $544,341 155,526
2026-03-31 $451,921 117,078
2025-12-31 $2,050,088 521,651
2025-09-30 $2,716,534 581,699
2025-06-30 $1,899,808 610,871
2025-03-31 $2,104,123 622,522
2024-12-31 $4,889,988 862,432
2024-09-30 $5,299,046 905,820
2024-06-30 $7,827,332 989,549
2024-03-31 $9,700,368 1,041,930
2023-12-31 $8,480,393 1,004,786
2023-09-30 $9,099,174 1,174,087
2023-06-30 $14,083,282 1,229,981
2023-03-31 $6,950,295 901,465
2022-12-31 $4,863,658 797,321
2022-09-30 $4,994,769 843,711
2022-06-30 $4,893,184 827,950
2022-03-31 $343,662 45,100
2021-12-31 $246,339 90,900
2021-09-30 $235,122 89,400
2021-06-30 $262,255 63,500
2021-03-31 $307,930 65,378